Rhone Ma Holdings Bhd - Asset Resilience Ratio
Rhone Ma Holdings Bhd (5278) has an Asset Resilience Ratio of 0.11% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 5278 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2025)
This chart shows how Rhone Ma Holdings Bhd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Rhone Ma Holdings Bhd (5278) total assets.
Liquid Assets Composition Over Time
This chart breaks down Rhone Ma Holdings Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Rhone Ma Holdings Bhd balance sheet liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM0.00 | 0% |
| Short-term Investments | RM292.65K | 0.11% |
| Total Liquid Assets | RM292.65K | 0.11% |
Asset Resilience Insights
- Limited Liquidity: Rhone Ma Holdings Bhd maintains only 0.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Rhone Ma Holdings Bhd Industry Peers by Asset Resilience Ratio
Compare Rhone Ma Holdings Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 0.50% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 9.65% |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062 |
Drug Manufacturers - Specialty & Generic | 1.18% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
Annual Asset Resilience Ratio for Rhone Ma Holdings Bhd (2020–2025)
The table below shows the annual Asset Resilience Ratio data for Rhone Ma Holdings Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.11% | RM292.65K ≈ $73.48K |
RM258.49 Million ≈ $64.90 Million |
-0.01pp |
| 2024-12-31 | 0.13% | RM282.85K ≈ $71.01K |
RM225.45 Million ≈ $56.60 Million |
+0.01pp |
| 2023-12-31 | 0.12% | RM273.04K ≈ $68.55K |
RM230.59 Million ≈ $57.89 Million |
-1.05pp |
| 2022-12-31 | 1.17% | RM2.56 Million ≈ $643.31K |
RM219.43 Million ≈ $55.09 Million |
-1.17pp |
| 2021-12-31 | 2.34% | RM4.58 Million ≈ $1.15 Million |
RM195.81 Million ≈ $49.16 Million |
-0.08pp |
| 2020-12-31 | 2.42% | RM4.51 Million ≈ $1.13 Million |
RM185.99 Million ≈ $46.70 Million |
-- |
About Rhone Ma Holdings Bhd
Rhone Ma Holdings Berhad, an investment holding company, engages in the manufacture, trading, marketing, and distribution of biotechnology and animal health products primarily in Malaysia. The company operates through Animal Health Products and Food Equipment; Food Ingredients; and others segments. It offers diagnostic laboratory analysis and consultation services to veterinary, agriculture, and … Read more